FDA Plans To Study Public’s Interpretation Of Drug Promotion

FDA is laying the groundwork to study how the general public interprets drug promotion. According to an FDA spokesperson, the agency hopes to prevent drug and medical device companies from misleading consumers and possibly creating life-threatening complications in the future. An FDA official recently cited specific examples of drug promotion that raised red flags, including a case where a manufacturer made myriad misleading claims about a product on its website. As part of the study plan laid out in a...